-
公开(公告)号：US20090148561A1
公开(公告)日：2009-06-11
申请号：US12367653
申请日：2009-02-09
Applicant: Martin ANTONSSON , Goran Molin
Inventor： Martin ANTONSSON , Goran Molin
CPC classification number: C12R1/225 , A23C9/1234 , A23C19/0323 , A23Y2220/63
Abstract: New strains of lactobacillus paracasei which can be used as probiotics in dairy products and which are characterized in surviving the gastrointestinal passage and giving a palatable cheese product when used as an adjunct in cheese manufacturing. The invention especially refers to the new strains Lactobacillus paracasei 8700:2, DSM 13434, and Lactobacillus paracasei 02A, DSM 13432. The invention also refers to dairy food products, such as cheese, containing said strains.
Abstract translation: 新的副干酪乳杆菌菌株，其可以用作乳制品中的益生菌，其特征在于在胃肠道通过中存活，并且当用作酪乳制造中的辅料时，产生可口的奶酪产品。 本发明特别涉及新的副干酪乳酸杆菌8700：2，DSM 13434和干酪乳酸杆菌02A，DSM 13432.本发明还涉及含有所述菌株的乳制食品，例如奶酪。
-
公开(公告)号：US5587314A
公开(公告)日：1996-12-24
申请号：US417770
申请日：1995-04-06
Applicant: Stig Bengmark , Siv Ahrne , Goran Molin , Bengt Jeppson
Inventor： Stig Bengmark , Siv Ahrne , Goran Molin , Bengt Jeppson
CPC classification number: C12R1/245 , A61K35/747 , C12R1/25 , Y10S435/853 , Y10S435/856 , Y10S435/857
Abstract: A process for isolation of a strain of Lactobacillus having the ability of being established on human intestinal mucosa in vivo and being able to remain therein after oral administration for at least 10 days after the completion of the administration. By the process the new strains L. plantarum 299 (DSM 6595) and L. casei ssp. rhamnosus 271 (DSM 6594) have been isolated, which are useful for the prophylaxis or treatment of bacterial infections, especially in the form of a fermented nutrient composition.
Abstract translation: 一种用于分离具有在体内在人肠粘膜上建立的能力的乳杆菌菌株的方法，并且在施用完成后口服给药至少10天后能够保留在其中。 通过该过程，新菌株植物乳杆菌299（DSM 6595）和干酪乳杆菌 已经分离了鼠李糖271（DSM 6594），其可用于预防或治疗细菌感染，特别是以发酵营养组合物的形式。
-
公开(公告)号：USRE46718E1
公开(公告)日：2018-02-20
申请号：US13910278
申请日：2013-06-05
Applicant: Goran Molin , Siv Ahrné , Bengt Jeppsson
Inventor： Goran Molin , Siv Ahrné , Bengt Jeppsson
IPC: C12N1/20 , A01N63/00 , A61K35/747 , A61K31/35 , A61K31/7032 , C12N9/18 , A23L33/135 , C12R1/25
CPC classification number: A61K31/35 , A23L33/135 , A23Y2220/67 , A61K31/7032 , A61K35/747 , C12N1/20 , C12N9/18 , C12R1/25 , C12Y301/0102 , Y10S435/857 , A61K2300/00
Abstract: The invention refers to a composition comprising one or more tannase-producing strains of Lactobacillus having the ability to adhere to the human intestinal mucosa in combination with tannin. New tannase-producing strains of Lactobacillus plantarum are a.
-
公开(公告)号：US08703472B2
公开(公告)日：2014-04-22
申请号：US12367653
申请日：2009-02-09
Applicant: Martin Antonsson , Goran Molin
Inventor： Martin Antonsson , Goran Molin
IPC: C12N1/20
CPC classification number: C12R1/225 , A23C9/1234 , A23C19/0323 , A23Y2220/63
Abstract: New strains of Lactobacillus paracasei which can be used as probiotics in dairy products and which are characterized in surviving the gastrointestinal passage and giving a palatable cheese product when used as an adjunct in cheese manufacturing. The invention especially refers to the new strains Lactobacillus paracasei 8700:2, DSM 13434, and Lactobacillus paracasei 02A, DSM 13432. The invention also refers to dairy food products, such as cheese, containing said strains.
Abstract translation: 新的副干酪乳杆菌（Lactobacillus paracasei），其可以用作乳制品中的益生菌，其特征在于在胃肠道通过中存活，并且当用作酪乳制造中的辅助剂时，产生可口的奶酪产品。 本发明特别涉及新的副干酪乳酸杆菌8700：2，DSM 13434和干酪乳酸杆菌02A，DSM 13432.本发明还涉及含有所述菌株的乳制食品，例如奶酪。
-
公开(公告)号：US08586026B2
公开(公告)日：2013-11-19
申请号：US12529498
申请日：2008-02-29
Applicant: Goran Molin , Siv Ahrne , Caroline Karlsson , Bengt Jeppsson
Inventor： Goran Molin , Siv Ahrne , Caroline Karlsson , Bengt Jeppsson
IPC: A01N63/00
CPC classification number: A61K35/747 , A23L33/135 , A23Y2220/67
Abstract: Use of one strain of Lactobacillus plantarum for the manufacture of a composition for increasing the diversity of the gastrointestinal tract by administration of said strain to an individual with a view to producing an increased diversity index compared to placebo is disclosed, as well as use of one strain of Lactobacillus plantarum for the manufacture of a composition for prophylactic treatment of a healthy individual against developing a low bacterial diversity (LBD); of an individual having LBD against developing one or more physiologically disturbed conditions, large intestine bacterial overgrowth (LIBO) or small intestine bacterial overgrowth (SIBO); and of an individual having LIBO or SIBO against developing one or more physiologically disturbed conditions, and a method for increasing said diversity.
Abstract translation: 公开了使用一株植物乳杆菌来制造用于通过向个体施用所述菌株来增加胃肠道多样性的组合物，以便与安慰剂相比产生增加的多样性指数，以及使用一种 用于制造用于预防性处理健康个体以防发展低细菌多样性（LBD）的组合物的植物乳杆菌菌株; 具有LBD的个体发生一种或多种生理紊乱条件，大肠细菌过度生长（LIBO）或小肠细菌过度生长（SIBO）; 以及具有LIBO或SIBO的个体发展一种或多种生理紊乱状况的个体以及增加所述多样性的方法。
-
Patent Agency Ranking
6.发明申请公开(公告)号：US20060269533A1
公开(公告)日：2006-11-30
申请号：US10543604
申请日：2004-01-27
Applicant: Goran Molin , Siv Ahrne , Bengt Jeppsson
Inventor： Goran Molin , Siv Ahrne , Bengt Jeppsson
CPC classification number: A61K35/745 , A23L33/135 , A23Y2300/45 , C12N1/20 , C12R1/01 , Y02A50/473
Abstract: The invention refers to new strains of Bifidobacterium, especially of the species Bifidobacterium infantis, having the ability to survive in the intestinal tract and to produce glutamine and optionally arginine in vivo, as well as to compositions comprising said strains.
Abstract translation: 本发明涉及具有在肠道中存活并在体内产生谷氨酰胺和任选的精氨酸的能力的双歧杆菌，特别是婴儿双歧杆菌的新菌株以及包含所述菌株的组合物。
-
公开(公告)号：US6159465A
公开(公告)日：2000-12-12
申请号：US913618
申请日：1997-09-23
Applicant: Ingegerd Adlerberth , Siv Ahrne , Bengt Jeppsson , Marie-Louise Johansson , Goran Molin , Agnes Wold
Inventor： Ingegerd Adlerberth , Siv Ahrne , Bengt Jeppsson , Marie-Louise Johansson , Goran Molin , Agnes Wold
CPC classification number: A61K35/747
Abstract: The invention refers to the use of Lactobacillus plantarum 299v having a mannose-specific adhesin for the preparation of a pharmaceutical composition inhibiting the binding of pathogenic bacteria expressing mannose-specific adhesins to the epithelial cell surface. The strain of Lactobacillus plantiarum which can be used in the invention adheres to D-mannose-coated agarose beads. The invention also refers to the use of said strain for the preparation of a pharmaceutical composition to be used in prophylatic and/or curative treatment of bacterial translocation, gastroenteritis and other diseases caused by pathogenic bacteria expressing mannose-specific adhesins.
Abstract translation: PCT No.PCT / SE96 / 00372 Sec。 371日期1997年9月23日 102（e）1997年9月23日PCT 1996年3月25日PCT公布。 公开号WO96 / 29083 日期1996年9月26日本发明涉及具有甘露糖特异性粘附素的植物乳杆菌299v用于制备抑制表达甘露糖特异性粘附素的病原性细菌与上皮细胞表面的结合的药物组合物的用途。 可用于本发明的植物乳杆菌的菌株粘附于D-甘露糖包被的琼脂糖珠上。 本发明还涉及所述菌株用于制备用于预防和/或治疗细菌易位，胃肠炎和由表达甘露糖特异性粘附素的病原菌引起的其它疾病的药物组合物的用途。
-
公开(公告)号：US20100143463A1
公开(公告)日：2010-06-10
申请号：US12529498
申请日：2008-02-29
Applicant: Goran Molin , Siv Ahrne , Caroline Karlsson , Bengt Jeppsson
Inventor： Goran Molin , Siv Ahrne , Caroline Karlsson , Bengt Jeppsson
CPC classification number: A61K35/747 , A23L33/135 , A23Y2220/67
Abstract: Use of one strain of Lactobacillus plantarum for the manufacture of a composition for increasing the diversity of the gastrointestinal tract by administration of said strain to an individual with a view to producing an increased diversity index compared to placebo is disclosed, as well as use of one strain of Lactobacillus plantarum for the manufacture of a composition for prophylactic treatment of a healthy individual against developing a low bacterial diversity (LBD); of an individual having LBD against developing one or more physiologically disturbed conditions, large intestine bacterial overgrowth (LIBO) or small intestine bacterial overgrowth (SIBO); and of an individual having LIBO or SIBO against developing one or more physiologically disturbed conditions, and a method for increasing said diversity.
Abstract translation: 公开了使用一株植物乳杆菌来制造用于通过向个体施用所述菌株来增加胃肠道多样性的组合物，以便与安慰剂相比产生增加的多样性指数，以及使用一种 用于制造用于预防性处理健康个体以防发展低细菌多样性（LBD）的组合物的植物乳杆菌菌株; 具有LBD的个体发生一种或多种生理紊乱条件，大肠细菌过度生长（LIBO）或小肠细菌过度生长（SIBO）; 以及具有LIBO或SIBO的个体发展一种或多种生理紊乱状况的个体以及增加所述多样性的方法。
-
公开(公告)号：US5474932A
公开(公告)日：1995-12-12
申请号：US989030
申请日：1993-04-16
Applicant: Stig Bengmark , Siv Ahrne , Goran Molin , Bengt Jeppson
Inventor： Stig Bengmark , Siv Ahrne , Goran Molin , Bengt Jeppson
CPC classification number: C12R1/245 , A61K35/747 , C12R1/25 , Y10S435/853 , Y10S435/856 , Y10S435/857
Abstract: A process for isolation of a strain of Lactobacillus having the ability of being established on human intestinal mucosa in vivo and being able to remain therein after oral administration for at least 10 days after the completion of the administration.By the process the new strains L. plantarum 299 (DSM 6595) and L. casei ssp. rhamnosus 271 (DSM 6594) have been isolated, which are useful for the prophylaxis or treatment of bacterial infections, especially in the form of a fermented nutrient composition.
Abstract translation: PCT No.PCT / SE92 / 00528 Sec。 371日期：1993年04月16日 102（e）日期1993年4月16日PCT提交1992年7月24日PCT公布。 出版物WO93 / 01823 日期：1993年2月4日。一种用于分离具有在体内在人肠粘膜上建立的能力的乳杆菌菌株的方法，并且在施用完成后至少10天口服后能够保留在其中。 通过该过程，新菌株植物乳杆菌299（DSM 6595）和干酪乳杆菌 已经分离了鼠李糖271（DSM 6594），其可用于预防或治疗细菌感染，特别是以发酵营养组合物的形式。
-
公开(公告)号：US07947482B2
公开(公告)日：2011-05-24
申请号：US10543604
申请日：2004-01-27
Applicant: Goran Molin , Siv Ahrne , Bengt Jeppsson
Inventor： Goran Molin , Siv Ahrne , Bengt Jeppsson
IPC: C12N1/20
CPC classification number: A61K35/745 , A23L33/135 , A23Y2300/45 , C12N1/20 , C12R1/01 , Y02A50/473
Abstract: The invention refers to new strains of Bifidobacterium, especially of the species Bifidobacterium infantis, having the ability to survive in the intestinal tract and to produce glutamine and optionally arginine in vivo, as well as to compositions comprising said strains.
Abstract translation: 本发明涉及具有在肠道中存活并在体内产生谷氨酰胺和任选的精氨酸的能力的双歧杆菌，特别是婴儿双歧杆菌的新菌株以及包含所述菌株的组合物。
-
-
-
-
-
-
-
-
-
Search Results
12
records
(took 0.013 seconds)
